Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302 million at an $849 million market cap. Hemab...read more
Thirteen IPOs raised a combined $7.3 billion in April, joined by two direct listings. While surging volatility in March weighed on new issuance early on, activity ended in line with April’s 10-year historical average by deal count (15) but well above by...read more
Silver Bow Mining, an exploration-stage mining company with projects in Montana, raised $60 million by offering 5.2 million shares at $11.50, the midpoint of the $10 to $13 range. The company offered 0.9 million more shares than anticipated. It originally filed ...read more
Updated Monday, 4/27. A handful of IPOs are currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Neuropsychiatric therapeutics biotech ...read more
US IPO Weekly Recap: Biotech, early-stage mining, and Bill Ackman close out the April IPO market
Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302 million at an $849 million market cap. Hemab...read more
Renaissance Capital’s April IPO Market Update
Thirteen IPOs raised a combined $7.3 billion in April, joined by two direct listings. While surging volatility in March weighed on new issuance early on, activity ended in line with April’s 10-year historical average by deal count (15) but well above by...read more
Exploration-stage mining company Silver Bow Mining prices upsized IPO at the $11.50 midpoint
Silver Bow Mining, an exploration-stage mining company with projects in Montana, raised $60 million by offering 5.2 million shares at $11.50, the midpoint of the $10 to $13 range. The company offered 0.9 million more shares than anticipated. It originally filed ...read more
US IPO Week Ahead: Biotechs, mining, and Bill Ackman deals set to debut
Updated Monday, 4/27. A handful of IPOs are currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Neuropsychiatric therapeutics biotech ...read more